GoodRx says approved peptides went through safety and effectiveness testing, while wellness versions lack that evidence and may carry risks.
Recap by typeshit. Full story at Herald-Review.com.
The Sunrise health expert says unregulated peptide use can put people in hospital, and in the worst cases leave them needing a new liver.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
Obesity specialist Beverly Tchang posts her top three takeaways on the science of amylin based drugs after speaking at an AAFP event.
His family says his BMI fell from 36 to 22.8 over two years on Wegovy, and he has since joined a cheer team. His doctor says the drug isn't right for every child.
Loading…